Institute of Biomedical Research Corp. MRES
0.00 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.0012 Day range 0.0012
0.0007 52-week range 0.0166
- YTD
- -57.14%
- 1 year
- -85.00%
News
accessnewswire.com RLAB & MRES: Tiago Henriques Joins M2MMA Combat Sports Promotion Advisory Board DUBAI, UAE / ACCESS Newswire / January 24, 2025 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, is an avant-garde powerhouse reshaping the combat sports landscape. It is thrilled to…
accesswire.com MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences DUBAI, UAE / ACCESSWIRE / November 25, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), operating as M2Bio Sciences, is a pioneering biotechnology company dedicated to advancing…
accesswire.com MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 22, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), a pioneering nutraceutical biotechnology company that delves into the innovative…
accesswire.com RLAB: M2MMA Welcomes Legendary Muay Thai Icon Sagat Petchyindee to Advisory Board! DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / May 16, 2024 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, a leader in mixed martial arts, is thrilled to announce the appointment of…
accesswire.com MRES: M2Bio Food and Beverage Wraps Up 2023/ 2024 Looking Ahead CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specialising in…
accesswire.com MRES: M2Bio Sciences Provides Corporate Update CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 1, 2024 / Institute of Biomedical Research Corporation (OTC PINK:MRES) is pleased to provide further details of the sale to Real American Capital…
accesswire.com MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 23, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in…
accesswire.com MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology,specializing in…
accesswire.com MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 9, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in…
accesswire.com Real American Announces Acquisition of M2MMA from MRES PALM SPRINGS, CA / ACCESSWIRE / January 30, 2024 / The Real American Capital Corporation (OTC PINK:RLAB) is pleased to announce the acquisition from Institute of Biomedical Research Corporation (OTC…
accesswire.com Real American Announces Appointment of Officers and Directors PALM SPRINGS, CA / ACCESSWIRE / January 18, 2024 / The Real American Capital Corporation (OTC PINK:RLAB) announced today the appointment of Jeff Robinson as Chairman and Director and Willem Jonker as…
accesswire.com MRES: M2MMA Gears Up for a Landmark Year in 2024 CAPE TOWN / ACCESSWIRE / January 2, 2024 / CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / January 2, 2024 / Institute of Biomedical Research Corp. (OTC PINK: MRES), a vanguard entity at the forefront of…
accesswire.com MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 15, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES): A pioneering force in nutraceutical biotechnology, specializing in alternative…
accesswire.com MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 14, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in…
accesswire.com African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 3, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in…
accesswire.com M2MMA Announces 2024 Fight Schedule and Appoints CEO CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / October 12, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in…
accesswire.com M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / October 2, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in…
accesswire.com M2Bio Sciences Closes JDAX Acquisition CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 21, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in…
accesswire.com M2Bio Sciences Pharmacology & Clinical Application of CBD CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 15, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in…
accesswire.com M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 13, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in…
benzinga.com Stocks That Hit 52-Week Lows On Tuesday